Copyright © 2008 B. Wilhelm et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. J. R. Zierath, D. Galuska, B.-L. Johansson, and H. Wallberg-Henriksson, “Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle,” Diabetologia, vol. 34, no. 12, pp. 899–901, 1991. View at Publisher · View at Google Scholar
2. J. R. Zierath, A. Handberg, M. Tally, and H. Wallberg-Henriksson, “C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation,” Diabetologia, vol. 39, no. 3, pp. 306–313, 1996. View at Publisher · View at Google Scholar
3. P. N. Shashkin, Y. Jiao, H. Westerblad, and A. Katz, “C-peptide does not alter carbohydrate metabolism in isolated mouse muscle,” American Journal of Physiology: Endocrinology and Metabolism, vol. 272, no. 2, pp. E245–E247, 1997.
4. C. Z. Wójcikokowski, V. Maier, K. Dominiak, R. Fussgänger, and E. F. Pfeiffer, “Effects of synthetic rat C-peptide in normal and diabetic rats,” Diabetologica, vol. 25, no. 3, pp. 288–290, 1983. View at Publisher · View at Google Scholar
5. G. J. Etgen, Jr., D. A. Fryburg, and E. M. Gibbs, “Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway,” Diabetes, vol. 46, no. 11, pp. 1915–1919, 1997. View at Publisher · View at Google Scholar
6. M. E. Young, G. K. Radda, and B. Leighton, “Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro,” Biochemical Journal, vol. 322, no. 1, pp. 223–228, 1997.
7. L. Li, Y. Oshida, M. Kusunoki, et al., “Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats,” Diabetologia, vol. 42, no. 8, pp. 958–964, 1999. View at Publisher · View at Google Scholar
8. Y. Sato, Y. Oshida, Y.-Q. Han, et al., “C-peptide fragments stimulate glucose utilization in diabetic rats,” Cellular and Molecular Life Sciences, vol. 61, no. 6, pp. 727–732, 2004. View at Publisher · View at Google Scholar · View at PubMed
9. B.-L. Johansson, S. Sjöberg, and J. Wahren, “The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients,” Diabetologia, vol. 35, no. 2, pp. 121–128, 1992. View at Publisher · View at Google Scholar
10. B.-L. Johansson, B. Linde, and J. Wahren, “Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients,” Diabetologia, vol. 35, no. 12, pp. 1151–1158, 1992. View at Publisher · View at Google Scholar
11. B. Wilhelm, M. M. Weber, K. Ekberg, et al., “Activation of glucose metabolism by C-peptide in patients with type 1 diabetes mellitus and in healthy control subjects,” Diabetes, vol. 56, p. A337, 2007.
12. J. Shafqat, E. Melles, K. Sigmundsson, et al., “Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects,” Cellular and Molecular Life Sciences, vol. 63, no. 15, pp. 1805–1811, 2006. View at Publisher · View at Google Scholar · View at PubMed
13. B.-L. Johansson, A. Kernell, S. Sjöberg, and J. Wahren, “Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1,” The Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 4, pp. 976–981, 1993. View at Publisher · View at Google Scholar
14. J. Wahren, “C-peptide: new findings and therapeutic implications in diabetes,” Clinical Physiology and Functional Imaging, vol. 24, no. 4, pp. 180–189, 2004. View at Publisher · View at Google Scholar · View at PubMed
15. T. Wallerath, T. Kunt, T. Forst, et al., “Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide,” Nitric Oxide, vol. 9, no. 2, pp. 95–102, 2003. View at Publisher · View at Google Scholar